Skip to main content

Structural Proteomics: An Opportunity Overview for Investors; Zoom Proteomics System; Applied Biosystems, Millipore, and PerkinElmer have released a joint offering; ProteomIQ

Premium

The study, “Structural Proteomics: An Opportunity Overview for Investors,” by John Sullivan, is now available through Multex at http://www.multexusa.com/products.asp, for $300. The study provides an overview of the field of structural proteomics, including recent technology developments and an analysis of company valuations. Sullivan is a drug discovery analyst at Stephens.

Invitrogen has released a suite of benchtop electrophoresis analysis equipment, IPG strips, and mini-gels for separating proteins. The products, grouped under the brandname Zoom Proteomics System, are designed for simplicity and convenience, the company said, and allow researchers to separate protein samples in under three hours.

Applied Biosystems, Millipore, and PerkinElmer have released a joint offering of in-gel digestion, sample cleanup, and protein identification instrumentation. The package consists of ABI’s Proteomics Solution MALDI-TOF mass spectrometer system, PerkinElmer’s MultiProbe II robotic liquid handler, and Millipore’s Montage In-Gel Digest96 kit.

Proteome Systems has released ProteomIQ, an integrated set of separation, robotics, and mass spectrometry technology, coupled with an enterprise-level computing platform. The platform contains technology contributions from IBM, Shimadzu Biotech, Millipore, Sigma-Aldrich, and Thermo Finnigan.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.